EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

Validation of Plasma Free Hemoglobin Testing for Extracorporeal Membrane Oxygenation (ECMO) Patients

Meshach Asare-Werehene, Mary Kathryn Bohn, Bianca Wan, Mark Alm, Ghislaine Douflé, Marc-André Gagnon, Gregory A Wasney, Elenita Tacsuan, Benjamin Jung, Davor Brinc iD

The Journal of Applied Laboratory Medicine · 2026

DOI: 10.1093/jalm/jfaf194 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift The Journal of Applied Laboratory Medicine, 2026. Verfasst von Meshach Asare-Werehene und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, ON, Canada. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, Hemoglobins. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agilent Technologies Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Circuit-induced hemolysis is relatively common in extracorporeal membrane oxygenation (ECMO) patients. Intravascular release of cell-free hemoglobin can lead to complications and requires timely recognition. Validation of plasma free hemoglobin (PFH) measurement using a direct spectrophotometric method is presented. Methodology We evaluated a method modified from Kahn et al. (Ann Clin Lab Sci 1981;11:126–31) on a stand-alone spectrophotometer (Cary 60) and compared its performance to the semiquantitative H-index on an Abbott Alinity c, including precision, linearity, recovery, reference interval verification, interference, and stability. Method comparison was performed relative to the H-index and the same method on a different spectrophotometer (Beckman DU 720). Lipemia interference was performed on the Cary 60, Cary 3500, and Beckman DU 720. Surrogate biomarkers for hemolysis detection were also investigated in ECMO patients.

Results

The PFH method on the Cary 60 demonstrated imprecision ranging from 1% (96.0 mg/dL) to 4% (3.0 mg/dL), linearity to 100 mg/dL, and recovery >80% for values >2 mg/dL hemoglobin-spiked plasma. Dilution expanded the reportable range to the maximum dilution tested (1000 mg/dL). Lipemia interfered with PFH measurement by the direct method, but the same method on the Cary 3500 was resistant to lipemia. Bilirubin did not cause significant interference. Direct and H-index methods were comparable with a mean difference of 5.03 mg/dL (95% CI −1.38, 11.44). Lactate dehydrogenase was the most reliable surrogate biomarker for hemolysis. with AUC of 0.921 (0.894, 0.949) at >50 mg/dL.

Conclusion

PFH measurement by a direct spectrophotometric method is more precise and sensitive compared to the H-index; however, PFH measurement is susceptible to lipemia unless performed on a high-end spectrophotometer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracorporeal Membrane OxygenationHemoglobinsHumansHemolysisSpectrophotometryReproducibility of ResultsBiomarkers

Substanzen

HemoglobinsBiomarkers

Autor:innen und Institutionen

  • Department of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, ON, Canada.
  • LifeLabs, Toronto, ON, Canada.
  • Inflammation and Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • Division of Clinical Biochemistry, Laboratory Medicine Program, University Health Network, Toronto, ON, Canada.
  • Department of Perfusion Services, Peter Munk Cardiac Centre, University Health Network, Toronto, ON, Canada.
  • Department of Perioperative Medicine and Pain Management, Toronto General Hospital, Toronto, ON, Canada.

ORCID-Profile: Davor Brinc

Förderung

  • Agilent Technologies Canada

Zitieren

APA

Asare-Werehene, M., Bohn, M. K., Wan, B., Alm, M., Douflé, G., Gagnon, M. A., Wasney, G. A., Tacsuan, E., Jung, B., & Brinc, D. (2026). Validation of Plasma Free Hemoglobin Testing for Extracorporeal Membrane Oxygenation (ECMO) Patients. The Journal of Applied Laboratory Medicine. https://doi.org/10.1093/jalm/jfaf194

Vancouver

Asare-Werehene M, Bohn MK, Wan B, Alm M, Douflé G, Gagnon MA, et al. Validation of Plasma Free Hemoglobin Testing for Extracorporeal Membrane Oxygenation (ECMO) Patients. The Journal of Applied Laboratory Medicine. 2026. doi:10.1093/jalm/jfaf194

BibTeX
@article{AsareWerehene2026,
  author = {Asare-Werehene, Meshach and Bohn, Mary Kathryn and Wan, Bianca and Alm, Mark and Douflé, Ghislaine and Gagnon, Marc-André and Wasney, Gregory A and Tacsuan, Elenita and Jung, Benjamin and Brinc, Davor},
  title = {Validation of Plasma Free Hemoglobin Testing for Extracorporeal Membrane Oxygenation (ECMO) Patients},
  journal = {The Journal of Applied Laboratory Medicine},
  year = {2026},
  doi = {10.1093/jalm/jfaf194}
}
Kostenlos starten →